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Abstract
A fructose-rich diet can induce metabolic syndrome, a combination of health disorders that
increases the risk of diabetes and cardiovascular diseases. Diet is also known to alter the
microbial composition of the gut, although it is not clear whether such alteration contributes
to the development of metabolic syndrome. The aim of this work was to assess the possible
link between the gut microbiota and the development of diet-induced metabolic syndrome in
a rat model of obesity. Rats were fed either a standard or high-fructose diet. Groups of fruc-
tose-fed rats were treated with either antibiotics or faecal samples from control rats by oral
gavage. Body composition, plasma metabolic parameters and markers of tissue oxidative
stress were measured in all groups. A 16S DNA-sequencing approach was used to evalu-
ate the bacterial composition of the gut of animals under different diets. The fructose-rich
diet induced markers of metabolic syndrome, inflammation and oxidative stress, that were
all significantly reduced when the animals were treated with antibiotic or faecal samples.
The number of members of two bacterial genera, Coprococcus and Ruminococcus, was
increased by the fructose-rich diet and reduced by both antibiotic and faecal treatments,
pointing to a correlation between their abundance and the development of the metabolic
syndrome. Our data indicate that in rats fed a fructose-rich diet the development of meta-
bolic syndrome is directly correlated with variations of the gut content of specific bacterial
taxa.
Introduction
It is well-established that a hypercaloric diet, rich in highly refined carbohydrates and fat
(Western diet), can induce a wide range of metabolic alterations, including obesity, increased
plasma triglyceride concentration, impaired glucose tolerance and insulin resistance [1–3]. A
major component of the Western diet is the common monosaccharide fructose, present either
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free or bound to glucose (i.e. sucrose). Free fructose is found in many fruits and vegetables and
is the most abundant component of sweeteners (hydrolyzed corn starch), that are now largely
used in western countries. It has been estimated that in the US the load of free fructose has
increased from 158.5 kcal per person per day in 1978 to 228 kcal per person per day in 1998
[3]. This substantial increase has paralleled the increased incidence of obesity, leading to the
hypothesis that a fructose-rich diet may contribute to the development of obesity and related
metabolic disorders [3–5]. However, the contribution of high-fructose diets to the development
of obesity remains controversial, since some authors have not observed unequivocal evidence
linking fructose consumption with metabolic disorders [2]. To address this issue, studies with
animal models have proven particularly informative [6]. A recent study performed with non-
human primates has shown that even in the absence of weight gain, fructose rapidly causes
liver damages and that hepatic steatosis relates to the duration of fructose consumption [7].
Previous experiments showed that, even if the caloric intake is the same, a fructose-rich diet
given to adult rats induced obesity (i.e. increased body lipids and increased epidydimal fat) as a
consequence of an increased de novo lipogenesis taking place in the liver [8]. In addition, we
found that long term consumption of the fructose-rich diet impaired glucose tolerance,
induced an oxidative stress status and increased plasma non-esterified-fatty-acids (NEFA) [9],
the latter being considered a reliable marker of the development of insulin resistance [10].
In the last decade the rapid development of metagenomic approaches has allowed the analy-
sis of microbial communities present in various districts of the human body. It is now clear
that the microbial community of the human gut is complex. It provides a relevant contribution
to the metabolic properties of the gastrointestinal tract and by consequence to the health status
of the host [11]. The composition of the gut microbiota is influenced by changes in environ-
mental factors, including diet [11–13]. It has been reported that the presence of specific nutri-
ents may have an influence on the composition of the microbial community, leading to
changes in the function of the microbiota [14–16].
In this context it is reasonable to assume that a fructose-rich diet could alter the composi-
tion of the gut microbiota. However, it is unknown how gut microbiota altered by a high fruc-
tose diet would affect overall health. Only very recent studies have started to address the
importance of microbiota in animal models or humans exposed to a fructose-rich diet [3].
Hsieh et al [17] reported that the oral administration of a probiotic strain of Lactobacillus reu-
teri improves insulin resistance and reduces hepatic steatosis in rats fed with a fructose-rich
diet, suggesting the probiotic-based approach as a promising therapeutic strategy in the treat-
ment of the metabolic syndrome and of the type 2 diabetes.
Here we show that the detrimental effects caused by fructose-induced metabolic syndrome
in adult rats were abolished by an antibiotic treatment, suggesting a direct involvement of the
microbiota in the induction of the metabolic syndrome. Similar effects, though less evident,
were observed when fructose-fed rats were inoculated with faecal samples of rats under stan-
dard diet, although they were less evident. A 16S DNA-based analysis of the gut microbiota of
the various animals was performed to evaluate the alteration of the macrobiotic gut community
composition in animals under different diets.
Materials and Methods
Animals and treatments
Male Sprague-Dawley rats (Charles River, Italy), of 100 days of age were used as a model of
diet-induced obesity [18]. They were caged singly in a temperature-controlled room (23±1°C)
with a 12-h light/dark cycle (06.30–18.30). Treatment, housing, and euthanasia of animals met
the guidelines set by the Italian Health Ministry. All experimental procedures involving
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animals were approved by “Comitato Etico-Scientifico per la Sperimentazione Animale” of the
University “Federico II” of Naples.
Rats were divided in two groups, each with the same mean body weight (460±10 g), that
were fed either with control diet (Mucedola 4RF21; Settimo Milanese, Milan, Italy) or with a
fructose-rich diet, known to induce early signs of obesity within 8 weeks of treatment [8, 9, 19].
The energy content of the two diets was the same, because the composition was the same,
except that half of the starch of the control diet had been substituted with fructose in the fruc-
tose-rich diet (Table 1). In addition, rats were pair-fed for the whole experimental period, by
giving them the same amount of diet, both as weight and as caloric content. Each rat consumed
the full portion of the diet fed them each day over the 8 week study period.
Rats fed the control diet were divided in two groups of six rats each: one group received
water supplemented with antibiotic mix (Ampicillin 1 g/L + neomycin 0.5 g/L) (CA rats),
while the second group did not receive any further treatment and served as control (C rats).
Rats fed the fructose-rich diet were divided in three groups, each composed of six rats: one
group received water supplemented with the above antibiotic mix (FA rats), the second group
was subjected to microbiota transplantation (FT rats), while the third group did not receive
any further treatment (F rats). Placebo gavage was given to all the rats.) The antibiotic mix
(Ampicillin + neomycin) was chosen because ampicillin is able to penetrate Gram-positive and
some Gram-negative bacteria, while neomycin has excellent activity against Gram-negative
bacteria, and has partial activity against Gram-positive bacteria. In addition, both antibiotics
are poorly absorbed (or unabsorbed as in the case of neomycin) and thus without any systemic
effects [20]. For microbiota transplantation, to ensure that each of the FT rats received a bacte-
rial load similar in number and species, stools from all six control animals were pooled and rats
Table 1. Composition of experimental diets.
CONTROL DIET FRUCTOSE DIET
Component (g/100 g)






AIN-76 mineral mix 1.6
AIN-76 vitamin mix 0.4
Choline 0.1
Methionine 0.1
Gross energy density, kJ/g 17.2 17.2
Metabolisable energy density, kJ/g * 11.1 11.1
Protein, % metabolisable energy 29.0 29.0
Lipids, % metabolisable energy 10.6 10.6





*estimated by computation using values (kJ/g) for energy content as follows: protein 16.736, lipid 37.656, and carbohydrate 16.736.
doi:10.1371/journal.pone.0134893.t001
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of group FT fed with aliquots of the pooled mixture. To this end, fresh faecal pellets (2 pellets
for each rat) from all six donor rats (C rats) were collected and placed in transfer buffer (pre-
reduced sterile phosphate buffered saline containing 0.05% cysteine HCl, 2 mL/g) on ice. The
faecal pellets were homogenized, centrifuged at 800g for 2 min and the supernatant was col-
lected. Diluted faecal supernatant was then orally inoculated to recipient rats (0.5 mL/rat)
every third day during the 8 weeks dietary treatment period. During the treatments, body
weight, food and water intake were monitored daily and no adverse effect was observed during
the whole experimental period.
Metabolic analysis
To perform the glucose tolerance test the day before the sacrifice, rats were fasted for 6 hours
from 09.00 a.m. A basal, postabsorptive blood sample was obtained from a small tail clip and
placed in EDTA—coated tubes and then glucose (2 g/kg body weight) was injected intraperito-
neally. Blood samples were collected after 20, 40, 60, 90, 120 and 150 min and placed in EDTA-
coated tubes. The blood samples were centrifuged at 1400xgav for 8 min at 4°C. Plasma glucose
concentration was measured by a colorimetric enzymatic method (Pokler Italia, Genova, Italy).
Plasma NEFA levels were measured by colorimetric enzymatic method (Roche Diagnostics,
Mannheim, Germany). Plasma tumor necrosis factor alpha (TNF-α) concentrations were
determined using a rat-specific enzyme linked immunosorbent assay (R&D Systems, MN,
USA) according to the manufacturer’s instruction. Plasma lipopolysaccharide (LPS) determi-
nations were performed using a kit based upon a Limulus amaebocyte extract (LAL kit; Lonza,
Basel, Switzerland).
To evaluate body energy and lipid content, sacrificed rats were killed by decapitation and
livers and hindleg skeletal muscles were quickly removed. Guts were cleaned of undigested
food and the carcasses were then autoclaved. After dilution into distilled water and subsequent
homogenisation of the carcasses, duplicate samples of the homogenised carcass were analyzed
for energy content by bomb calorimeter [9]. Total body lipid content was measured by the
Folch extraction method [21].
Isolation of epididymal adipocytes and measurement of in vitro lypolitic
capacity
Adipocytes were isolated from intra-abdominal epididymal white adipose tissue (WAT) as pre-
viously reported [20]. Aliquots corresponding to 15000 cells were then incubated in the pres-
ence of 1 μM isoproterenol, with or without 0.1 μM insulin, for 2 h at 37°C in a shaking bath.
At the end of the incubation, aliquots were used for the determination of glycerol production,
by incubating samples with Sigma glycerol reagent at 37°C for 15 min and then monitoring
absorbance at 540 nm against appropriate standards.
Preparation of whole tissue homogenates from liver and skeletal muscle
Whole tissue homogenates were prepared from liver and skeletal muscle as previously reported
[9, 22]. The extent of the peroxidative processes in whole tissue homogenates was determined
by measuring the level of lipid hydroperoxides according to Heath & Tappel [23]. Determina-
tion of protein oxidative damage was performed measuring protein-bound carbonyl levels by
the procedure of Reznick & Packer [24].
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Western blot quantification of p-Akt in skeletal muscle tissue
Skeletal muscle tissue samples were homogenized in lysis buffer containing 20 mM Tris-HCl
(pH 7.5), 150 mM NaCl, 2.7 mM KCl, 5% (v/v) glycerol, 1% (v/v) Triton X-100 and 50 μl/g tis-
sue of protease inhibitor cocktail (all from Sigma-Aldrich Corp., St. Louis, MO, USA) using a
Potter homogeniser, shaken for 2 h at 4°C, and centrifuged at 14000 x g for 20 min at 4°C. The
supernatants were collected and aliquots were denatured, subjected to electrophoresis and the
gels were transferred onto PVDF membranes (Millipore, MA, USA). After preblocking, the
membranes were incubated overnight at 4°C with polyclonal antibody for the phosphorylated
form of kinase Akt (p-Akt, Cell Signaling, MA, USA, diluted 1:1000 in blocking buffer). After
washing, the membranes were incubated 1 hour at room temperature with a anti-rabbit, alka-
line phosphatase-conjugated secondary antibody (Promega, WI, USA), and then incubated at
room temperature with a chemiluminescent substrate, CDP-Star (Sigma-Aldrich, MO, USA).
Data detection was carried out by exposing autoradiography films (Eastman Kodak Company,
NY, USA) to the membranes. Quantification of signals was carried out by Un-Scan-It gel soft-
ware (Silk Scientific, UT, USA). Kinase Akt was detected with polyclonal antibody (Cell Signal-
ing, MA, USA, diluted 1:1000 in blocking buffer) and used to normalize the p-Akt signal.
Caecal sample preparation, DNA extraction and measurement of caecal
glucose and fructose
The ceacal content of 30 rats (six replicates for each of five different fed groups) was squeezed
out, collected separately and immediately placed onto dry ice. The total genomic DNA was
extracted in triplicate from 200 mg of each caecal microbioma sample using the QIAamp DNA
Stool Mini Kit (QIAGEN) following the manufacturer’s instructions.
Caecal content of glucose and fructose was assessed by using colorimetric enzymatic meth-
ods (Pokler Italia, Genova, Italy for glucose and Sigma-Aldrich Co., Saint Louis, MO for
fructose).
PCR and amplicon preparation
Primers designed by Caporaso et al. [25] (515F: 5'-GTGCCAGCMGCCGCGGTAA-3') and
Wang et al. [26] (939R: 5'-CTTGTGCGGGCCCCCGTCAATTC-3') were used to amplify a
400nt region of the 16S rRNA gene. The amplicon covers the hyper variable regions V4 and
V5. Each 25 μl PCR mix contained 2X Phusion Master Mix (BioLabs Inc., New England),
10 μM of each PAGE-purified primer (Microsynth, Switzerland) and 50 ng of template-DNA.
The PCR conditions used were 98°C for 30s, 15 cycles of 98°C for 10s, 52°C for 30s and 72°C
for 30s, followed by 72°C for 10min using a SensoQuest PCR cycler (Germany). The PCR prod-
ucts were checked for their length on 1,5% agarose gel with GelRed Nucleic Acid Gel Stain
(Biotium Inc., USA) and purified with DNA clean and concentrator-5 kit (Zymo Research, U.
S.A). The DNA concentration was determined using Qubit 2.0 Fluorometer and Qubit dsDNA
HS Assays Kit (Invitrogen, Life Technologies).
Illumina library preparation
Index libraries for the purified PCR products were prepared using the TruSeq Nano DNA Sam-
ple Prep Kit (HT) following manufacturer’s recommended protocols (Illumina, Inc., San
Diego, Ca, USA). The quantity of the different libraries were assessed by qPCR using the
Kappa Library Quantification Kit (KAPA Biosystems Inc., USA). Paired-End sequencing (PE-
250) was performed on an Illumina MiSeq at the Genomic Diversity Centre (GDC) at the
ETH, Zurich, Switzerland following manufacturer’s recommended protocols (Illumina, Inc.,
Faecal Transplant and Metabolic Syndrome
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San Diego, CA, USA). The MiSeq Control Software Version 2.4 including MiSeq Reporter 2.4
was used for the primary analysis and the de-multiplexing of the raw reads.
Bioinformatics analyses
Raw reads (reads per run = 1 x107; reads per sampleﬃ 3 x 105) were quality checked with
FastQC (v0.11.2) and overlapping forward and reverse reads were merged and error corrected
(minimum overlap 15, maximum overlap 200, and maximum mismatch density 0.25) using
FLASh (v.1.2.9,) [27]. Reads that could not be merged were excluded from further analysis.
Primer region were identified and trimmed off the ends of the merged reads using Cutadapt
(v.1.4) allowing no mismatches. In a subsequent step, the merged and trimmed reads were
quality filtered using PrinSeq Lite (v.0.20.4). Reads with mean quality below 25 or any reads
containing ambiguous nucleotides (i.e. “N”) were removed. The remaining cleaned reads were
de-noised (identity threshold 99%) and chimera checked (de-novo and reference based against
the 16S gold reference database provided by QIIME) using Usearch [28] version 6. The reads
were binned using reference mapping applying the Usearch option as part of QIIME version
1.6.0 [29]. The remaining reads were passed to the QIIME pipeline. Uclust [23] was used to
define Operational Taxonomic Units (OTUs) at 97% sequence identity, which were assigned a
taxonomy using the RDP classifier [30]. Representative sequences for each OTU were aligned
with PyNast [31] and columns uninformative for phylogeny building were filtered out using
Greengenes [32]. The resulting alignments were used to build a phylogeny using FastTree [33].
The principal coordinates analysis (PCoA) was performed on pairwise unweighted UniFrac
distances [34]. The sequencing data have been deposited in Sequence Read Archive (SRA),
accession number SRP060322.
Statistical analysis
Data are given as means±SEM of six different rats. Statistical analyses were performed by one-
way analysis of variance followed by Tukey post hoc test. Probability values less than 0.05 were
considered significant. All analyses were performed using GraphPad Prism 4 (GraphPad Soft-
ware, San Diego, CA, USA). The Analysis of Similarity (ANOSIM) was performed by QIIME
and used to assess the difference in OTU composition between samples collected after different
treatments. ANOSIM provides an R statistics, which can range from -1 to 1 (albeit values< 0
are rarely obtained). R values> 0.75 indicate well separated microbial compositions; R> 0.5
overlapping, but clearly different communities; and R< 0.25 practically not separable commu-
nities. The significance of ANOSIM test was assessed using a randomization procedure
whereby the value R was recomputed 999 times.
Results
Antibiotics or faecal samples do not affect the fructose-induced increase
in body energy and lipid content
A first metabolic characterization was carried out by analyzing the animal whole body compo-
sition. As shown in Fig 1, fructose-fed rats displayed significantly higher body energy (panel
A), lipids (panel B) and epididymal fat compared to controls. The treatment with antibiotics or
faecal samples did not affect the increase in body energy (Fig 1A) or lipids (Fig 1B and 1C) due
to the diet. No significant difference was found in final body weight (C = 538±20; CA = 540
±15; F = 541±15; FA = 537±17; FT = 540±23 g) and in body weight gain (C = 78±5; CA = 80
±5; F = 81±8; FA = 77±7; FT = 80±3 g) between the five groups of rats. Since changes in energy
intake are the primary drive of obesity development, metabolisable energy (ME) intake was
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monitored throughout the experimental period to verify whether the fructose-induced increase
in body energy and lipid content was due to an increase of ME. To this aim, food intake and
energy loss through faeces and urines were analyzed (Methods) and indicated that ME intake
was similar in all experimental groups (C = 19,700±1,200 kJ, CA = 19,400±1,050 kJ, F = 19,500
±1,100 kJ, FA = 19,200±990 kJ, FT = 19,500±1,000 kJ). In addition, the caecal content of glu-
cose and fructose was measured to assess whether dietary treatment could modify substrate
availability in the hindgut, but no significant variation en caecal glusose and fructose was
found between the five groups of rats (S1 Table).
Antibiotics or faecal samples reduce markers of the fructose-induced
metabolic syndrome
The levels of plasma NEFA and glucose intolerance were followed as early markers of the
development of metabolic derangement and insulin resistance. Fig 2A shows that the signifi-
cant increase in plasma NEFA found in fructose-fed rats (group F vs C) was almost completely
reversed by treatment with antibiotics (group FA) or faecal samples (group FT). In addition,
the inhibitory effect of insulin on lipolysis in epididymal WAT was nearly absent in fructose-
fed rats (group F), but was completely restored by treatment with antibiotics (group FA) or fae-
cal samples (group FT) (Fig 2B).
Changes in plasma glucose after the administration of a given dose of glucose were plotted
over the time and the area under the curves was calculated and used to estimate glucose toler-
ance. The significantly higher values observed in fructose-fed rats (group F vs C) indicate that,
with the same glucose injection, the increase in plasma glucose levels was more marked in fruc-
tose-fed rats (Fig 2C, inset). This reduced glucose tolerance was abolished by antibiotic treat-
ment (group FA), while the treatment with faecal samples only slightly increased glucose
tolerance (Fig 2C). To assess the contribution of skeletal muscle to changes in glucose toler-
ance, we investigated a distal effector of insulin signalling in this tissue, and we found that pAkt
levels were significantly lower in fructose-fed (group F) and fructose-fed+faecal samples
(group FT) rats, while this decrease was abolished by antibiotic treatment (group FA) (Fig 2D
and S1 Fig).
As markers of obesity-induced inflammation, the plasma concentration of LPS and TNF-
alpha were considered, since metabolic endotoxaemia is associated with obesity, metabolic syn-
drome and type 2 diabetes [35]. A statistically significant increase in plasma LPS levels was
Fig 1. Antibiotics or faecal samples do not affect the fructose-induced increase in body energy and lipid content. Animal whole body composition
was obtained by measurement of body energy (panel A), lipids (panel B) and epididymal fat (C) content in control (C), control+antibiotic (CA), fructose-fed
(F), fructose-fed+antibiotic (FA) and fructose-fed+faecal samples (FT) rats. Values are reported as means±SEM of six different rats. * P< .05 (one-way
ANOVA followed by Tukey post-test).
doi:10.1371/journal.pone.0134893.g001
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Fig 2. Antibiotics or faecal samples reducemarkers of the fructose-inducedmetabolic syndrome. Plasma NEFA (A) and inhibitory effect of insulin on
lipolysis in epididymal WAT (B) were assessed as first markers of metabolic syndrome. Changes in plasma glucose after the administration of a given dose of
glucose were plotted over the time (C) and the area under the curves was calculated and used to estimate glucose tolerance (inset in panel C), while the
contribution of skeletal muscle to changes in glucose tolerance was estimated by measuring the degree of phosphorylation of the kinase Akt, a distal effector
of insulin signalling in this tissue (D). As a third marker of the development of a metabolic syndrome, the plasma concentration of LPS (E) and TNF-alpha (F)
were considered. Values obtained in control (C), control+antibiotic (CA), fructose-fed (F), fructose-fed+antibiotic (FA) and fructose-fed+faecal samples (FT)
rats are reported as means±SEM of six different rats. * P< .05 (one-way ANOVA followed by Tukey post-test). EU = endotoxin unit.
doi:10.1371/journal.pone.0134893.g002
Faecal Transplant and Metabolic Syndrome
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measured in fructose-fed rats and was partly reduced by both treatments, with antibiotic and
faecal samples (Fig 2E). In addition, plasma concentrations of TNF-alpha were found four-fold
higher in fructose-fed rats than in control animals (Fig 2F) and both antibiotic treatment and
faecal transplant were able to completely abolish this increase (Fig 2F).
Antibiotics or faecal samples reduce the fructose-induced tissue
oxidative stress
Oxidative damage in liver and skeletal muscle was evaluated by assessing the levels of damaged
lipids (panels A and C of Fig 3) and proteins (panels B and D of Fig 3) in both tissues. Fruc-
tose-fed rats showed higher levels of oxidative stress than control rats in liver (panels A and B
of Fig 3) and skeletal muscle (panels C and D of Fig 3). Treatments with antibiotics or faecal
samples totally or partially reversed the effect in both tissues, respectively (Fig 3).
Gut microbial composition
In order to investigate the effect of the fructose-rich diet on the gut microbial composition and
the efficacy of the faecal transplant in abolishing such effects we used a 16S DNA-sequencing
approach. As detailed below, the analysis on samples for rats of the control group was in agree-
ment with previous data for rats under standard diet regimen with Firmicutesmuch more
abundant than Bacteroidetes, Proteobacteria and Tenericutes [36].
The identified phylotypes show that Firmicutes were the most abundant bacteria in all five
diet groups (97–77%) while Bacteroidetes, Proteobacteria and Tenericutes were always less rep-
resented (19–2%, 2–0.5% and 0.2–0.07%, respectively) (Fig 4A). A significant increase in the
number of Bacteroidetes was observed in the gut of animals treated with antibiotics (Fig 4A).
At the class level, Clostridia are the most abundant organisms in all five groups, followed by
Bacilli in groups C, F and FT and by Bacteroidia in CA and FA (Fig 4B). Independently from
the diet regimen, Bacilli were almost totally absent in the gut of animals treated with antibiotics
(Fig 4B).
The bacterial content of the samples was estimated by Chao1 algorithm (alpha-diversity
metric) and showed a decreased microbial complexity in samples CA and FA compared to the
other three groups (Fig 5A). This is not surprising and indicates that the antibiotic treatment
had strongly altered the gut microbial composition causing a reduction of the microbial diver-
sity. In order to analyze relationships among samples based on differences in phylogenetic
diversity (beta-diversity metric), principle coordinates (PC) were calculated using UniFrac dis-
tances [34] between samples. Sample distribution in the PCoA plot (Fig 5B) clearly showed
two main clusters, one containing CA and FA samples and another one containing C, F and FT
samples. Similar results were obtained when the PCoA plot was rerun exclusively with C, F and
FT rats (S2 Fig). Results of Fig 5, in agreement with the taxonomical assignment at phylum and
class level of Fig 4 indicate that the microbial composition of the caecum of animals treated
with antibiotics completely differs from that of animals not under antibiotic treatment. Because
of the strong alterations, only data from animals not treated with antibiotics (C, F and FT
groups) were considered for further analysis. The detailed composition of microbiota from CA
and FA rats is reported in S3 Fig.
The overall microbial composition of the gut of rats of groups C, F and FT at the genus level
were altered by the different diets and treatments (global R = 0.71 p< 0.001). The most abun-
dant genera (mostly belonging to the Clostridia class) appeared similarly represented in the gut
of all three groups (Fig 6).
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A more detailed analysis of groups C and F showed that the representativeness of eight gen-
era and of the Coriobacteriaceae family (in bold in Table 2) was significantly different (P< .05)
and suggested an effect of the fructose-rich diet on those bacteria.
For these eight genera and one family we then analyzed data of the FT group and observed
that the representativeness of two genera, Coprococcus and Ruminococcus, and of the Coriobac-
teriaceae family was restored to levels similar to those observed in the C group (P< .05) (Fig
7). These results suggest a direct correlation between the number of members of the Coprococ-
cus and Ruminococcus genera and of the Coriobacteriaceae family present in the gut and the
development of the metabolic syndrome.
For this reason we also analyzed the presence of these three bacterial groups in rats of the
CA and FA groups, that do not have signs of metabolic syndrome. In both antibiotic-treated
groups the representativeness of the Coprococcus and Ruminococcus genera was lower than in
the F group (Table 3), thus supporting a direct correlation between their representativeness
and the development of the metabolic syndrome. For the Coriobacteriaceae family such corre-
lation was, instead, not supported by the analysis of the antibiotic-treated groups (Table 3).
Fig 3. Antibiotics or faecal samples reduce the fructose-induced tissue oxidative stress.Oxidative damage in liver (A, B) and skeletal muscle (C, D)
was evaluated by assessing the levels of damaged lipids (A, C) and proteins (B, D) in control (C), control+antibiotic (CA), fructose-fed (F), fructose-fed
+antibiotic (FA) and fructose-fed+faecal samples (FT) rats. Values are reported as means±SEM of six different rats. * P< .05 (one-way ANOVA followed by
Tukey post-test).
doi:10.1371/journal.pone.0134893.g003
Faecal Transplant and Metabolic Syndrome
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Discussion
The main result of this study is that in fructose-fed rats the development of metabolic syn-
drome directly correlates with the alteration of the microbial composition of the gut. Markers
Fig 4. Relative Operational Taxonomic Units (OTUs) abundance at the Phylum (A) or Class (B) level in
control (C), control+antibiotic (CA), fructose-fed (F), fructose-fed+antibiotic (FA) and fructose-fed
+faecal samples (FT) rats. The bar plot shows how the caecal microbiota distribution of each sample
changes in rats of the various groups.
doi:10.1371/journal.pone.0134893.g004
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of metabolic syndrome, increased in fructose-fed rats, are reversed by treatment with an antibi-
otic mixture and partly by faecal transplant of rats under standard diet.
It has been recently reported that microbiota transplantation through surgical extraction of
donor caecal content and administration to the recipient rats by oral gavage was able to reshape
indigenous gut microbial community to an extent not previously anticipated [36]. Here we
show that a similar reshaping can be obtained without the need of surgical extraction of caecal
bacteria, but simply using faecal content, and, more importantly, that the reshaping of gut
microbiota occurs in concomitance with metabolic improvement in obese rats.
The animal model used in the present study is represented by adult rats that became obese
after long-term feeding with a fructose-rich diet [8, 9, 20]. Fructose-fed obese rats also display
increased plasma NEFA, a reliable marker of the development of insulin resistance [10], but
this metabolic alteration is fully reversed by treatment with antibiotic or faecal samples. In
addition, the inhibition of lipolysis by insulin in WAT is almost completely lost in fructose-fed
rats, but treatment with antibiotic or faecal samples is able to restore insulin sensitivity at the
level of control rats.
The loss of insulin sensitivity in WAT can be driven by inflammation [37], and here we
show that fructose-fed rats exhibited higher plasma LPS and TNF-α, that could therefore con-
tribute to derangements in WAT function. Treatment with antibiotic or faecal samples in fruc-
tose-fed rats greatly reduced plasma LPS and completely abolishes the increase in plasma TNF-
α, and these changes could be at the basis of the restored insulin sensitivity in WAT in these
Fig 5. Variation of bacterial composition in/among the samples in control (C), control+antibiotic (CA), fructose-fed (F), fructose-fed+antibiotic (FA)
and fructose-fed+faecal samples (FT) rats. (A) Alpha-diversity plot. The Chao1 species richness estimator indicates a higher microbial complexity in the C,
F, FT groups than in the CA and FA groups. Values are reported as means±SEM of six different rats. (B) Beta-diversity is shown by Principal Coordinates
Analysis (PCoA), based on UniFrac method. The plot displays two main clusters: C, F and FT belong to cluster I (straight line), while CA and FA belong to
cluster II (dashed line).
doi:10.1371/journal.pone.0134893.g005
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Fig 6. Relative Operational Taxonomic Units (OTUs) abundance at the genus level in control (C), fructose-fed (F), and fructose-fed+faecal samples
(FT) rats.Composition of caecal microbiota of rats from different diet groups as revealed by Illumina sequencing of V4-V5 hypervariable region of 16S rRNA
gene. Population analyses for each diet group show phylotypes at genus level (when it was possible) and are reported as means of six rats for each diet
group (globalR = 0.71 p < 0.001, Analysis of Similarity).
doi:10.1371/journal.pone.0134893.g006
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rats. The increased plasma LPS in fructose-fed rats and its reversal by antibiotic treatment is in
agreement with previous findings obtained in mice made obese by high fat or high-fructose
diet [38–40]. The increased gut permeability that can be deduced from increased plasma LPS
has been documented also in fructose-fed mice through a decrease in the expression of the pro-
teins of the tight junctions, probably arising from the cellular stress imposed to enterocytes by
the uncontrolled metabolism of fructose by fructokinase [41]. On the other hand, we cannot
exclude that administration of faecal extracts was only marginally reversing the effect of fruc-
tose diet on plasma LPS, because it caused an increase in total intestinal LPS. However, to our
knowledge, our study is the first to show partial reversal of systemic inflammation in response
to treatment with faecal transplantation.
The glucose intolerance found in fructose-fed rats was abolished by treatment with antibi-
otic but not by faecal transplant. The lack of effect of faecal transplant on glucose tolerance in
the present study is at variance with results obtained in human studies [42], but it should be
taken into account that in the cited experiment the transplant was carried out by duodenal
gavage, whereas in the present study we have used oral gavage. Skeletal muscle greatly contrib-
utes to glucose disposal under the control of insulin [43], so we investigated a distal effector of
insulin signalling in skeletal muscle, the kinase Akt. The degree of Akt activation was reduced
Table 2. Bacteria differentially distributed in the caecum of control and fructose-fed rats.
Phylum Class Order Family Genus C group* F group* P valueC versus F
Bacteroidetes Bacteroidia Bacteroidales Bacteroidaceae Bacteroides 0.0310±0.01 0.0040±0.004 0.0499567
Firmicutes Bacilli Bacillales Staphylococcaceae 0.0390±0.01 0.0260±0.005 0.379299
Staphylococcus 0.0150±0.005 0.0040±0.002 0.113753
Lactobacillales Enterococcaceae Enterococcus 0.0300±0.003 0.0960±0.03 0.077031
Lactobacillaceae 13.0820±3.6 8.4010±2.4 0.069455
Lactobacillus 0.6050±0.03 0.3640±0.07 0.0352972
Clostridia Clostridiales Clostridiaceae 1.0710±0.03 1.1860±0.013 0.524552
Clostridium 2.7640±0.9 0.3590±0.07 0.0462856
Dehalobacteriaceae Dehalobacterium 0.1810±0.03 0.2640±0.01 0.0635174
Lachnospiraceae 49.978±1.7 45.7570±2.1 0.0544198
Anaerostipes 0.1580±0.02 0.1090±0.02 0.182093
Blautia 0.0150±0.005 0.0530±0.02 0.122038
Coprococcus 3.0780±0.1 4.1950±0.2 0.0042314
Dorea 0.1260±0.02 0.1530±0.03 0.502034
Roseburia 0.0180±0.005 0.0700±0.02 0.0411975
Peptococcacaee rc4-4 0.6130±0.06 1.3010±0.1 0.0028319
Peptostreptococcaceae 1.4240±0.8 0.0180±0.01 0.130464
Ruminococcacae 7.9680±0.7 6.3220±1.1 0.23389
Oscillospira 2.5100±0.3 3.2970±0.3 0.137306
Ruminococcus 2.9680±0.02 3.5280±0.09 0.0007972
Coriobacteriales Coriobacteriaceae 0.0450±0.02 0.1580±0.01 0.0051196
Erysipelotrichi Erysipelotrichales Erysipelotrichaceae 0.6320±0.6 0.6500±0.5 0.968611
Eubacterium 0.0320±0.02 0.0090±0.009 0.106268
Coprobacillaceae 0.1990±0.07 0.8520±0.7 0.126056
Coprobacillus 0.0290±0.01 0.0830±0.01 0.0007489
Tenericutes Mollicutes RF39 0.1050±0.07 0.2610±0.1 0.144464
* Percentage of Operational Taxonomic Units abundance in the sample. The values are reported as means ± SEM of six different rats.
P< .05 values are reported in bold and indicate a signiﬁcant difference between control (C) and fructose-fed (F) rats.
doi:10.1371/journal.pone.0134893.t002
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by fructose-rich diet but significantly increased in fructose-fed rats treated with antibiotic.
Since LPS directly induces insulin resistance in skeletal muscle [44], and antibiotic treatment
completely abolished the diet-induced increase in plasma LPS, we can hypothesize that LPS
could contribute to the development of glucose intolerance induced by high fructose diet.
Our present results highlight an increased oxidative damage to lipid and proteins in liver
and skeletal muscle of fructose-fed rats, which is fully prevented by antibiotic treatment, and
only partly reversed by faecal transplant. This pattern of variation can be explained by modula-
tion of plasma LPS by diet and treatments, since LPS has a well known pro-oxidant effect [45].
The reduction of all markers of metabolic syndrome, inflammation and tissue oxidative
stress in fructose-fed animals under antibiotic treatment clearly indicates that the metabolic
disorders are somehow due to the fructose-induced alteration of the gut microbiota. On the
other hand, the lack of any effect of antibiotic treatment on metabolic parameters in rats fed a
standard diet suggests that gut microbiota exerts a negative impact on the metabolic phenotype
of the rat only in fructose-induced pathologic conditions. As expected, the gut microbial com-
position of rats under antibiotic treatment strongly differed from that of animals not treated
with antibiotics and was characterized by a reduced diversity.
Fig 7. Taxonomical units restored by faecal transplantation. The histograms show the restoration of two genera and one family distributions after faecal
trasplantation. Their increase, due to the fructose-rich diet, is rescued by the faecal treatment. Values are reported as means±SEM of six different rats. * P<
.05 (one-way ANOVA followed by Tukey post-test). C = control, F = fructose-fed, FT = fructose-fed+faecal samples.
doi:10.1371/journal.pone.0134893.g007
Table 3. Representativeness of bacterial groups rescued by faecal transplant and antibiotic treatment.
Family Genus Group
C F FT CA FA
Lachnospiraceae Coprococcus 3.078 ± 0.1 4.195 ± 0.2* 2.600 ± 0.3** 1.100 ± 0.3** 0.500 ± 0.08**
Ruminococcacae Ruminococcus 2.968 ± 0.02 3.528 ± 0.09* 2.480 ± 0.2** 3.000± 0.1** 2.700 ± 0.2**
Coriobacteriaceae 0.045 ± 0.02 0.158 ± 0.01* 0.029 ± 0.01** 0.610 ± 0.05** 0.420 ± 0.12**
The values are expressed as percentage of Operational Taxonomic Units abundance and are reported as means ± SEM of six different rats. C = control,
F = fructose-fed, FT = fructose-fed+faecal samples, CA = control+antibiotic, FA = fructose-fed+antibiotic. rats. (*p< .05 compared to C rats, ** P < .05
compared to F rats, one-way ANOVA followed by Tukey post-test).
doi:10.1371/journal.pone.0134893.t003
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The fructose-rich diet altered the microbial composition of the gut with eight bacterial gen-
era and a family that significantly differed between rats of groups C and F. The lack of differ-
ence in caecal content of glucose and fructose in the five different grouos of rats let us to
hypothesize that the effect of fructose-rich is diet is not mediated by changes in substrate avail-
ability in the hindgut.
For two of those genera, Coprococcus and Ruminococcus, and for members of the Coriobac-
teriaeae family, the representativeness was rescued by the faecal treatment and, therefore,
directly correlated with the reduction of markers of metabolic syndrome, inflammation and tis-
sue oxidative stress. Consistently, the representativeness of the two bacterial genera was also
very low in the antibiotic-treated rats, that did not show signs of metabolic alterations. Those
results point to a member of the Coprococcus and Ruminococcus genera as directly involved in
the fructose-driven metabolic syndrome.
Coprococcus and Ruminococcus are two genera of the Lachnospiraceae family of Clostridia
respectively grouping three and thirteen species. These two genera have been included in the
list of about 160 bacterial groups dominating the human gastro-intestinal tract [46] and have
never been associated to diseases or gut inflammations before. We report here, for the first
time, a correlation between the relative abundance of members of the Coprococcus and Rumi-
nococcus genera and markers of metabolic syndrome.
Metabolic and inflammation markers induced by the fructose-rich diet were completely res-
cued by the antibiotic treatment and only partially rescued by the faecal transplant. At least
two alternative working hypotheses can explain the different responses to the two treatments.
A first possible explanation is that the antibiotic treatment reduced or totally eliminated bacte-
ria relevant for the development of the metabolic syndrome, present in animals of the F group
and in part also in the FT group. An alternative possibility is suggested by data of Table 2, indi-
cating that bacteria of the Coprococcus genus were more drastically affected by the antibiotic
treatment (from 4.19% to 0.5% of relative OTU abundance between F and FA groups) than by
the faecal transplant (from 4.19% to 2.6% of relative OTU abundance between F and FT), and
therefore pointing to the relative abundance of members of the Coprococcus genus in animals
under a fructose-rich diet as important for the development of the metabolic syndrome. Fur-
ther experiments will be needed to solve this point that represents a challenging future task.
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